A supercharged HIV vaccine could offer strong protection with just one injection, a study in mice has indicated.. Developed by researchers from the Massachusetts Institute of Technology (MIT) and , In a quiet lab where biotechnology and immunology collide, researchers may have taken a major step toward one of medicine’s most elusive goals: a single-shot vaccine for HIV. It’s a disease that has defied decades of scientific effort, evolving like a ghost through the immune system, always a step ahead of the body’s defenses., Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with just one vaccine dose, by adding two powerful adjuvants — materials that help stimulate the immune system. In a study of mice, the researchers showed that this approach produced a much wider diversity of […], Researchers from MIT and the Scripps Research Institute have unveiled a potent vaccine strategy capable of generating a robust immune defense against HIV with just a single dose. By fusing two powerful immune-boosting agents known as adjuvants, scientists have paved the way for a potentially game-changing leap in vaccine technology., Researchers at MIT and the Scripps Research Institute have unveiled a groundbreaking vaccine approach that may revolutionize the way we combat persistent infectious diseases such as HIV and SARS-CoV-2. By harnessing a synergistic combination of two powerful adjuvants within a single vaccine dose, this method elicits a, .